These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21209614)

  • 21. Study designs in clinical research.
    Noordzij M; Dekker FW; Zoccali C; Jager KJ
    Nephron Clin Pract; 2009; 113(3):c218-21. PubMed ID: 19690439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodological quality of pharmacogenetic studies: issues of concern.
    Jorgensen AL; Williamson PR
    Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesia and anesthesia for neonates: study design and ethical issues.
    Anand KJ; Aranda JV; Berde CB; Buckman S; Capparelli EV; Carlo WA; Hummel P; Lantos J; Johnston CC; Lehr VT; Lynn AM; Maxwell LG; Oberlander TF; Raju TN; Soriano SG; Taddio A; Walco GA
    Clin Ther; 2005 Jun; 27(6):814-43. PubMed ID: 16117988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
    Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
    Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of adaptive clinical trial designs in pharmacogenetic research.
    van der Baan FH; Knol MJ; Klungel OH; Egberts AC; Grobbee DE; Roes KC
    Pharmacogenomics; 2012 Apr; 13(5):571-8. PubMed ID: 22462749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
    Wang SJ
    Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring.
    Haufroid V; Picard N
    Ther Drug Monit; 2019 Apr; 41(2):121-130. PubMed ID: 30883506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Company profile: PGXIS Ltd.
    McCarthy A
    Pharmacogenomics; 2011 Sep; 12(9):1253-6. PubMed ID: 21919604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumers' views of pharmacogenetics--A qualitative study.
    Haddy CA; Ward HM; Angley MT; McKinnon RA
    Res Social Adm Pharm; 2010 Sep; 6(3):221-31. PubMed ID: 20813335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics and personalized medicine: the future for drug prescribing.
    Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
    J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein therapeutics: new applications for pharmacogenetics.
    Krejsa C; Rogge M; Sadee W
    Nat Rev Drug Discov; 2006 Jun; 5(6):507-21. PubMed ID: 16763661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review on the design and reporting of studies on drug-gene interaction.
    Smits KM; Schouten JS; Smits LJ; Stelma FF; Nelemans P; Prins MH
    J Clin Epidemiol; 2005 Jul; 58(7):651-4. PubMed ID: 15939214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic biomarkers for predicting drug response.
    Bank PC; Swen JJ; Guchelaar HJ
    Expert Rev Mol Diagn; 2014 Jul; 14(6):723-35. PubMed ID: 24857685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
    Fabbri C; Zohar J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():36-44. PubMed ID: 29777729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A question-based approach to adopting pharmacogenetics to understand risk for clinical variability in pharmacokinetics in early drug development.
    Evers R; Blanchard RL; Warner AW; Cutler D; Agrawal NG; Shaw PM
    Clin Pharmacol Ther; 2014 Sep; 96(3):291-5. PubMed ID: 25141952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current and future state of pharmacogenomics medical education in the USA.
    Nickola TJ; Green JS; Harralson AF; O'Brien TJ
    Pharmacogenomics; 2012 Sep; 13(12):1419-25. PubMed ID: 22966890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics research: a potential strategy for drug development.
    Wen JG; Wu L; Pu XX; He FZ; Liu MZ; Zhou HH; Zhang W
    Pharmazie; 2015 Jul; 70(7):437-45. PubMed ID: 26373203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics and anaesthesia: the value of genetic profiling.
    Landau R; Bollag LA; Kraft JC
    Anaesthesia; 2012 Feb; 67(2):165-79. PubMed ID: 22251108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.